ArticleEuropean journal of medicinal chemistry2026

Development of GS-441524 derivatives as potent SARS-CoV-2 Mac1 inhibitors via a direct-to-biology approach.

Kewen Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.